Patient management by cyclosporine C2 monitoring.
Jorga
Anamarija
A
Johnston
Atholl
A
Holt
David W
DW
D003175:Complement C2 / Q000032:analysis*; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008991:Monitoring, Physiologic
D003175:Complement C2; D007166:Immunosuppressive Agents; D016572:Cyclosporine